drugset / Trial / NCT05890534
Pycnogenol® in Post-COVID-19 Condition
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To determine the effect of Pycnogenol® versus placebo on patient-reported health status in people with post COVID-19 condition.
Timeline
- Start
- 2023-06-07
- Primary completion
- 2024-11-05
- Completion
- 2025-01-31
Publications
- Braun J, Kopp J, Kunzi L, Puhan MA, Fehr JS, Radtke T. Measurement properties of the 30-second sit-to-stand test in post COVID-19 condition: Results from the PYCNOVID randomised controlled trial. PLoS One. 2026 May 12;21(5):e0348275. doi: 10.1371/journal.pone.0348275. eCollection 2026.
- Radtke T, Kunzi L, Kopp J, Rasi M, Braun J, Zens KD, Winter B, Anagnostopoulos A, Puhan MA, Fehr JS. Effects of Pycnogenol(R) in people with post-COVID-19 condition (PYCNOVID): study protocol for a single-center, placebo controlled, quadruple-blind, randomized trial. Trials. 2024 Jun 15;25(1):385. doi: 10.1186/s13063-024-08187-6.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MARITIME PINE | Traditional medicine (herbal / TCM) | 200 mg | — |